Anti-human CD4 induces peripheral tolerance in a human CD4+, murine CD4-, HLA-DR+ advanced transgenic mouse model

Journal of Immunology

Volumn 169, Issue 6, 2002, Pages 2947-2955

  Laub, Rüdiger ^a   Brecht, Rene ^a   Dorsch, Martina ^a   Valey, Ulrich ^a   Wenk, Kerstin ^a   Emmrich, Frank ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLINERGIC RECEPTOR; HLA DR ANTIGEN; LYSOZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MAX 16H5; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TRANSGENIC MOUSE;

EID: 0037105614     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.6.2947     Document Type: Article

References (43)

1. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
2. Induction of tolerance by monoclonal antibody therapy
3. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: Studies with soluble antigens in intact mice
4. + cells
5. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction
6. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells
7. Prevention of acute murine cardiac allograft rejection: Anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling
8. Kinetics of induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation: A critical period of time is required for development of immunological unresponsiveness
9. Amplification of natural regulatory immune mechanisms for transplantation tolerance
10. Positive signal transduction via surface CD4 molecules does not need coexpression of the CD3/TcR complex
11. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen
12. Signals transduced through the CD4 molecule interfere with TCR/CD3-mediated ras activation leading to T cell anergy/apoptosis
13. Distinct signaling properties identify functionally different CD4 epitopes
14. lck plays a key role in transducing apoptotic signals in T cells
15. Gene activating and proapoptotic potential are independent properties of different CD4 epitopes
16. A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses
17. Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells
18. Replacement of murine by human CD4 and introduction of HLA-DR17 in mice: A triple-transgenic animal model to study human MHC II-CD4 interaction in situ
19. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice
20. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4
21. Rapid HLA-DRBI genotyping by nested PCR amplification
22. Delineation of several DR-restricted tetanus toxin T cell epitopes
23. An example of immunodominance: Engagement of synonymous TCR by invarianf CDR3Β
24. + cells on tetanus and diphtheria toxins
25. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein I (msp-1(19)) and T helper epitopes of tetanus toxoid
26. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4
27. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
28. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8
29. Modulation of the CD4 molecule is a major event in the induction of transplantation tolerance with anti-CD4 monoclonal antibodies
30. Nondepleting anti-CD4 antibodies in transplantation: Evidence that modulation is far less effective than prolonged CD4 blockade
31. Induction of transplantation tolerance using a nondepleting anti-CD4 mAb and donor-specific transfusion before transplantation: Evidence that a critical period of time is required for the development of immunological unresponsiveness
32. "Infectious" transplantation tolerance
33. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen
34. + T cell-mediated graft rejection
35. + suppressor T cells that are not dependent upon IL-4
36. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts
37. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells
38. Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2
39. Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function
40. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3
41. Engagement of the CD4 receptor inhibits the interleukin-2-dependent proliferation of human T cells transformed by Herpesvirus saimiri
42. The anti-CD4 mAb Max. 16H5 induces a switch from Th1 cytokines to Th2 cytokines in human peripheral mononuclear cells
43. CD4 dimerization and oligomerization: Implications for T-cell function and structure-based drug design